Justin Walsh
Stock Analyst at Jones Trading
(1.78)
# 3,020
Out of 4,829 analysts
36
Total ratings
34.38%
Success rate
-9.77%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLNN Clene | Initiates: Buy | $30 | $2.68 | +1,019.40% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $36.00 | - | 1 | Apr 2, 2025 | |
| BLRX BioLineRx | Downgrades: Hold | n/a | $3.11 | - | 2 | Apr 2, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $122 | $80.08 | +52.35% | 8 | Mar 21, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $5.64 | +95.04% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $2.26 | +696.46% | 1 | Dec 16, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $42 | $10.23 | +310.56% | 1 | Oct 18, 2024 | |
| THTX Theratechnologies | Downgrades: Hold | n/a | $2.53 | - | 2 | Oct 11, 2024 | |
| YMAB Y-mAbs Therapeutics | Initiates: Buy | $23 | $4.02 | +472.14% | 1 | Jul 11, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $15 → $22 | $2.44 | +803.49% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.07 | +215.89% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.48 | +706.45% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.89 | +349.44% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $1.39 | +1,344.04% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.17 | +10,704.32% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $2.46 | +17,786.18% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.65 | +11,420.74% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $26.10 | -23.37% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.92 | +10,316.67% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.99 | +403.78% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $800 | $7.67 | +10,330.25% | 1 | Sep 2, 2021 |
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $2.68
Upside: +1,019.40%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $36.00
Upside: -
BioLineRx
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.11
Upside: -
Lantheus Holdings
Mar 21, 2025
Maintains: Buy
Price Target: $127 → $122
Current: $80.08
Upside: +52.35%
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $5.64
Upside: +95.04%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $2.26
Upside: +696.46%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $10.23
Upside: +310.56%
Theratechnologies
Oct 11, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.53
Upside: -
Y-mAbs Therapeutics
Jul 11, 2024
Initiates: Buy
Price Target: $23
Current: $4.02
Upside: +472.14%
Perspective Therapeutics
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $2.44
Upside: +803.49%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.07
Upside: +215.89%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $2.48
Upside: +706.45%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.89
Upside: +349.44%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $1.39
Upside: +1,344.04%
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $0.17
Upside: +10,704.32%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $2.46
Upside: +17,786.18%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.65
Upside: +11,420.74%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $26.10
Upside: -23.37%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.92
Upside: +10,316.67%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $1.99
Upside: +403.78%
Sep 2, 2021
Initiates: Buy
Price Target: $800
Current: $7.67
Upside: +10,330.25%